MPO and prostate cancer: Myeloperoxidase is associated with many cancer types, including lung, ovarian, colorectal, and prostate cancers (Arslan, Pinarbasi & Silig, 2011; Li et al., 2011; Castillo-Tong et al., 2014; Zou et al., 2018) through the −463G/A promoter polymorphism.